title: Prospects of using phytoadaptogen in the treatment of diffuse stomach cancer.
abstract: The efficiency of treatment of diffuse stomach cancer can be improved by using a complex phytoadaptogen. In groups receiving phytoadaptogen, the level of tumor marker CA 19-9 decreased and the mean life span of patients increased by 2.5 times. The drug exhibited immunomodulating (including interferonogenic and adhesiogenic), antioxidant, and hormone-modulating effects.
authors.affiliation: N. N. Blokhin National Oncological Research Center, Russian Academy of Medical Sciences, Moscow, Russia. planta39@rambler.ru
authors.forename: O A
authors.initials: OA
authors.lastname: Bocharova
authors.forename: M I
authors.initials: MI
authors.lastname: Davydov
authors.forename: A A
authors.initials: AA
authors.lastname: Klimenkov
authors.forename: A Yu
authors.initials: AY
authors.lastname: Baryshnikov
authors.forename: R V
authors.initials: RV
authors.lastname: Karpova
authors.forename: S V
authors.initials: SV
authors.lastname: Chulkova
authors.forename: E G
authors.initials: EG
authors.lastname: Gorozhanskaya
authors.forename: V A
authors.initials: VA
authors.lastname: Ilyenko
mesh_terms: D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D006801:Humans; D007372:Interferons / Q000096:biosynthesis; D008875:Middle Aged; D013274:Stomach Neoplasms / Q000188:drug therapy* / Q000276:immunology / Q000601:surgery
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D007372:Interferons